Homogeneous trials present a missed opportunity to discover treatments that might be highly successful in a particular subset of patients.
Khalid Matin, MD, FACP
Advertisement
Articles by Khalid Matin, MD, FACP
Advertisement
Latest Updated Articles
Community-Based Programs Have the Power to Remove Clinical Trial BarriersPublished: July 20th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5